Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Cawachi: Half-year Ordinary Profits Remarkably Up 17.8%
November 19, 2001
- 3 NCEs Including Remicade Recommended to Be Approved
November 19, 2001
- Consumers Take Health-Oriented Foods for Better Nutritional Balance: JMARI Survey
November 19, 2001
- BULLETIN
November 19, 2001
- OTC NEWS IN BRIEF
November 19, 2001
- Precautions of 4 Drugs Including Carboplatin Revised Due to ADR
November 19, 2001
- WORLD NEWS IN BRIEF
November 19, 2001
- REGULATORY NEWS IN BRIEF
November 19, 2001
- Sankyo Aims at US Sales of \360 Bil. in FY2010
November 19, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 19, 2001
- Shionogi to Increase Overseas Sales to 10% of Total Sales in 2005
November 19, 2001
- NEW PRODUCTS
November 19, 2001
- Otsuka, BMS File NDA for New Antipsychotic Aripiprazole with FDA
November 19, 2001
- Philips Medical Launches New Stethoscopes
November 19, 2001
- Japanese Global Strategy Update (7)
November 19, 2001
- Regulations Related to Medical Devices to Be Reviewed
November 19, 2001
- Takeda: 7.7% Sales Increase Attributable to Int'l Strategic Products
November 19, 2001
- Terumo: Sales Up 7.3%, Profits Down
November 19, 2001
- Santen: Independent Marketing in US Pushes Up Sales
November 19, 2001
- Iressa Effective against NSCLC: PII Results in Int'l Joint Trial
November 19, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…